Isolation and characterization of faecal bifidobacteria and lactobacilli isolated from dogs and primates

Anaerobe

Volumn 29, Issue , 2014, Pages 108-112

  Strompfová, Viola ^a   Lauková, Andrea ^a  

^a INSTITUTE OF ANIMAL PHYSIOLOGY   (Slovakia)

Author keywords

Bifidobacterium; Dog; Faeces; Lactobacillus; Primates

Indexed keywords

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; ALPHA GALACTOSIDASE; ALPHA MANNOSIDASE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ARYL ACYLAMIDASE; BETA GALACTOSIDASE; CHYMOTRYPSIN A; CYS ARYLAMIDASE; ERYTHROMYCIN; ESTERASE; ESTERASE LIPASE; GENTAMICIN; LEU ARYLAMIDASE; METRONIDAZOLE; N ACETYL BETA GLUCOSAMINIDASE; OXACILLIN; PENICILLIN DERIVATIVE; PHOSPHATASE; TETRACYCLINE; UNCLASSIFIED DRUG; VAL ARYLAMIDASE; VANCOMYCIN; ANTIINFECTIVE AGENT; PROBIOTIC AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BIFIDOBACTERIUM; BIFIDOBACTERIUM ANIMALIS; BILE; CEBUS APELLA; COLONY FORMING UNIT; CONTROLLED STUDY; DOG; ENZYME ACTIVITY; ERYTHROCEBUS; EULEMUR FULVUS; FECES MICROFLORA; FEMALE; GRAM NEGATIVE BACTERIUM; LACTOBACILLUS; LACTOBACILLUS MURINUS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS REUTERI; MACACA FASCICULARIS; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PAPIO HAMADRYAS; PEDIOCOCCUS ACIDILACTICI; PRIMATE; PRIORITY JOURNAL; STOMACH JUICE; ANIMAL; ANTIBIOSIS; CHEMISTRY; DRUG EFFECTS; FECES; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PHYSIOLOGY;

BIFIDOBACTERIUM; BIFIDOBACTERIUM ANIMALIS; CANIS FAMILIARIS; CEBUS APELLA; ERYTHROCEBUS PATAS; EULEMUR FULVUS; LACTOBACILLUS; LACTOBACILLUS MURINUS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS REUTERI; MACACA FASCICULARIS; NEGIBACTERIA; PAPIO HAMADRYAS; PEDIOCOCCUS ACIDILACTICI; PRIMATES;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBIOSIS; BIFIDOBACTERIUM; BILE; DOGS; FECES; FEMALE; GASTRIC JUICE; GENTAMICINS; GRAM-NEGATIVE BACTERIA; LACTOBACILLUS; MALE; MICROBIAL SENSITIVITY TESTS; PRIMATES; PROBIOTICS; TETRACYCLINE;

EID: 84901413682     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2013.10.007     Document Type: Article

References (35)

1. Tannock G.W. Normal microflora. An introduction to microbes inhabiting the human body 1995, Chapman & Hall, London.
2. Isolauri E., Salminen S., Ouwehand A.C. Probiotics. Best Pract Res Clin Gastroenterol 2004, 18:299-313.
3. Simpson J.M., Martineau B., Jones W.E., Ballam J.M., Mackie R.I. Characterization of fecal bacterial populations in canines: effects of age, breed and dietary fiber. Microb Ecol 2002, 44:186-197.
4. Handl S., Dowd S.E., Garcia-Mazcorro J.F., Steiner J.M., Suchodolski J.S. Massive parallel 16S rRNA gene pyrosequencing reveals highly diverse fecal bacterial and fungal communities in healthy dogs and cats. FEMS Microbiol Ecol 2011, 76:301-310.
5. Ley R.E., Lozupone C.A., Hamady M., Knight R., Gordon J.I. Worlds within worlds: evolution of the vertebrate gut microbiota. Nat Rev Microbiol 2008, 6:776-788.
6. Garcia-Mazcorro J.F., Lanerie D.J., Dowd S.E., Paddock C.G., Grützner N., Steiner J.M., et al. Effect of a multi-species synbiotic formulation on fecal bacterial microbiota of healthy cats and dogs as evaluated by pyrosequencing. FEMS Microbiol Ecol 2011, 78:542-554.
7. Bunešová V., Vlková E., Rada V., Ročková Š., Svobodová I., Jebavý L., et al. Bifidobacterium animalis subsp. lactis strains isolated from dog faeces. Vet Microbiol 2012, 160:501-505.
8. Ushida K., Uwatoko Y., Adachi Y., Soumah A.G., Matsuzawa T. Isolation of bifidobacteria from feces of chimpanzees in the wild. JGen Appl Microbiol 2010, 56:57-60.
9. Rinkinen M.L., Koort J.M., Ouwehand A.C., Westermarck E., Björkroth K.J. Streptococcus alactolyticus is the dominating culturable lactic acid bacterium species in canine jejunum and feces of four fistulated dogs. FEMS Microbiol Lett 2004, 230:35-39.
10. O'Mahony D., Barry Murphy K., MacSharry J., Boileau T., Sunvold G., Reinhart G., et al. Portrait of a canine probiotic Bifidobacterium - from gut to gut. Vet Microbiol 2009, 139:106-112.
11. Mercenier A., Pavan S., Pot B. Probiotics as biotherapeutic agents: present knowledge and future prospects. Curr Pharm Des 2003, 9:175-191.
12. Delgado S., O'Sullivan E., Fitzgerald G., Mayo B. Substractive screening for probiotic properties of Lactobacillus species from the human gastrointestinal tract in the search for new probiotics. JFood Sci 2007, 72:310-315.
13. Matsumoto M., Sakamoto M., Benno Y. Dynamics of fecal microbiota in hospitalized elderly fed probiotic LKM512 yogurt. Microbiol Immunol 2009, 53:421-432.
14. Lee J.-H., O'Sullivan D.J. Genomics insights into Bifidobacteria. Microbiol Mol Biol Rev 2010, 74:378-416.
15. Kelley R.L., Park J.S., O'Mahony L., Minikhiem D., Fix A. Safety and tolerance of dietary supplementation with a canine-derived probiotic (Bifidobacterium animalis strain AHC7) fed to growing dogs. Vet Ther 2010, 11:E1-E14.
16. Strompfová V., Marciňáková M., Simonová M., Bogovič-Matijašić B., Lauková A. Application of potential probiotic Lactobacillus fermentum AD1 strain in healthy dogs. Anaerobe 2006, 12:75-79.
17. Biagi G., Cipollini I., Pompei A., Zaghini G., Matteuzii D. Effect of a Lactobacillus animalis strain on composition and metabolism of the intestinal microflora in adult dogs. Vet Microbiol 2007, 124:160-165.
18. Baillon M.-L., Marshall-Jones Z.V., Butterwick R. Effects of probiotic Lactobacillus acidophilus strain DSM13241 in healthy dogs. Am J Vet Res 2004, 65:338-343.
19. Bessède E., Angla-gre M., Delagarde Y., Sep Hieng S., Ménard A., Mégraud F. Matrix-assisted laser-desorption/ionization BIOTYPER: experience in the routine of a University hospital. Clin Microbiol Infect 2011, 17:533-538.
20. Arboleya S., Ruas-Mediedo P., Margolles A., Solís G., Salminen S., de los Reyes-Gavilán C.G., et al. Characterization and invitro properties of potentially probiotic Bifidobacterium strains from breast-milk. Int J Food Microbiol 2011, 149:28-36.
21. Jacobsen C.N., Rosenfeldt Nielsen V., Hayford A.E., Møller P.L., Michaelsen K.F., Pærregaard A., et al. Screening of probiotics activities of forty-seven strains of Lactobacillus spp., by invitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl Environ Microbiol 1999, 65:4949-4956.
22. Vinderola C.G., Mocchiutti P., Reinheimer J.A. Interactions among lactic acid starter and probiotic dairy products. JDairy Sci 2002, 85:721-729.
23. Kim S.Z., Adachi Y. Biological and genetic classification of canine intestinal lactic acid bacteria and bifidobacteria. Microbiol Immunol 2007, 51:919-928.
24. Lentsner A.A., Lentsner Kh.P., Mikel'saar M.E., Tiuri M.E., Troshin A.A. Species composition of intestinal lactoflora of healthy rhesus monkeys. Zh Mikrobiol Epidemiol Immunobiol 1989, 6:11-15. [in Russian].
25. Handwerger S., Pucci M.J., Volk K.J., Liu J., Lee M.S. Vancomycin-resistant Leuconostoc mesenteroides and Lactobacillus casei synthesize cytoplasmic peptidoglycan precursors that terminate in lactate. JBacteriol 1994, 176:260-264.
26. European Commission Opinion of the FEEDAP panel on the updating of the criteria used in the assessment of bacteria for resistance to antibiotics of human or veterinary importance. EFSA J 2005, 223:1-12.
27. Masco L., Van Hoorde K., De Brandt E., Swings J., Huys G. Antimicrobial susceptibility of Bifidobacterium strains from humans, animals and probiotic products. JAntimicrob Chemother 2006, 58:85-94.
28. Lidbeck A., Nord C.E., Gustafsson J.A., Rafter J. Lactobacilli, anticarcinogenic activities and human intestinal microflora. Eur J Cancer Prev 1992, 1(5):341-353.
29. Hussain M., Khan N.T., Wajid A., Rasool S.A. Technological characterization of indigenous enterococcal population for probiotic potential. Pak J Bot 2008, 40:867-875.
30. Peremulter K., Fraga M., Zunino P. Invitro activity of potential probiotic Lactobacillus murinus isolated from the dog. JAppl Microbiol 2008, 104:1718-1725.
31. Delgado S., O'Sullivan E., Fitzgerald G., Mayo B. Invitro evaluation of the probiotic properties of human intestinal Bifidobacterium species and selection of new probiotic candidates. JAppl Microbiol 2008, 104:1119-1127.
32. Piard J.C., Desmazeaud M. Inhibiting factors produced by lactic acid bacteria. 1. Oxygen metabolites and catabolism end-products. Lait 1991, 71:525-541.
33. Hütt P., Shchepetova J., Lõivukene K., Kullisaar T., Mikelsaar M. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens. JAppl Microbiol 2006, 100:1324-1332.
34. Kim P.I., Jung M.Y., Chang Y.-H., Kim S., Kim S.-J., Park Y.-H. Probiotic properties of Lactobacillus and Bifidobacterium strains isolated from porcine gastrointestinal tract. Appl Microbiol Biotechnol 2007, 74:1103-1111.
35. Prasad J., Gill H., Smart J., Gopal P.K. Selection and characterisation of Lactobacillus and Bifidobacterium strains for use as probiotics. Int Dairy J 1998, 8:993-1002.